Switch to:
More From Other Websites
[$$] Punishing the Cure Makers Won’t End Cancer Feb 08 2016
Celgene, Gilead Sciences shares could rise 30 percent: Barron's Feb 07 2016
How Analysts Value Gilead Now After Earnings Feb 06 2016
[$$] Celgene and Gilead: Two Drugmakers, 30% Upside Feb 06 2016
3 trades to watch as stock pain continues Feb 05 2016
3 safe trades in today's market Feb 05 2016
Gilead's Glory Days Are Over -- Here's Why You Should Dump the Stock Feb 05 2016
Gilead Sciences (GILD) Stock Gets ‘Outperform’ Rating at Leerink Feb 05 2016
Gilead Sciences: Why Slowing Hep-C Sales Don't Matter Feb 05 2016
It’s Time to Buy This Biotech Gem Feb 04 2016
25 Companies That Could Still Buy Back Mountains Of Stock Feb 04 2016
Gilead Sciences, Inc. Earnings Analysis: 2015 By the Numbers Feb 04 2016
Why M&A Delay Can Spell Disaster for Gilead Stock Feb 04 2016
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Intrexon and NewLink Feb 04 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK